ATG23 Antibody

What cellular processes is ATG23 involved in, and why is it important to study?

ATG23 is a peripheral membrane protein essential for the cytoplasm-to-vacuole targeting (Cvt) pathway in yeast and is required for efficient nonselective autophagy . Research has shown that ATG23 exists primarily as a homodimer with an extended rod-like structure spanning approximately 320 Å . The protein plays a critical role in membrane dynamics by interacting directly with membranes, primarily through electrostatic interactions, which enables vesicle tethering . Additionally, ATG23 interacts with ATG9, a transmembrane protein essential for Cvt vesicle and autophagosome formation . Studies with atg23Δ mutants demonstrate defective Cvt trafficking and decreased levels of autophagy under nitrogen starvation conditions, highlighting its important regulatory role in these cellular processes .

What should be considered when selecting ATG23 antibodies for immunoprecipitation experiments?

When selecting ATG23 antibodies for immunoprecipitation (IP), researchers should consider several factors based on the protein's characteristics:

• Epitope location: Choose antibodies targeting epitopes away from known interaction domains, particularly the coiled-coil domain (CC1) which mediates interactions with Ypt1 and the amphipathic helix region that facilitates dimerization .

• Antibody format: For co-IP studies of ATG23 interactions, consider using tag-specific antibodies against epitope-tagged ATG23 constructs, as demonstrated in studies using ATG23-MYC, ATG23-PA, or ATG23-3×HA variants .

• Validation in knockout backgrounds: Test antibody specificity in atg23Δ backgrounds to ensure signal specificity. Multiple knockout (MKO) backgrounds lacking 25 autophagy genes have been used successfully to verify direct interactions without interference from other autophagy proteins .

• Buffer conditions: When investigating membrane-associated interactions, use appropriate lysis conditions that preserve membrane integrity while still allowing antibody access to the target protein .

How can ATG23 antibodies be used to study protein localization?

ATG23 antibodies can be effectively used to study protein localization through multiple methodological approaches:

• Immunofluorescence microscopy: ATG23 typically distributes in subcellular punctate organelles, with one of the ATG23-positive structures co-localizing with the pre-autophagosomal structure (PAS), the potential site of Cvt vesicle/autophagosome formation . When performing immunofluorescence, use fixation methods that preserve membrane structures since ATG23 is a peripheral membrane protein.

• Subcellular fractionation validation: Confirm antibody specificity for subcellular fractionation studies by detecting ATG23 in appropriate fractions (typically P13, P100, and S100). Previous studies have used differential centrifugation to separate high-speed supernatant (S100) and pellet (P100) fractions, followed by immunoblotting to track ATG23 distribution .

• Co-localization studies: ATG23 antibodies can be combined with markers for the PAS (such as RFP-Ape1) to study co-localization events. Research has shown highly colocalized signaling between ATG23 and RFP-Ape1, indicating PAS localization .

• Bimolecular fluorescence complementation (BiFC): While not directly using antibodies, this approach with fusion reporters (e.g., ATG23-VN and VC-Ypt1) can complement antibody-based localization studies to monitor direct interactions in living cells .

How can researchers study ATG23 dimerization using antibodies?

ATG23 dimerization is a critical aspect of its function that can be studied using several antibody-based techniques:

• Co-immunoprecipitation of differently tagged constructs: Express two differently tagged versions of ATG23 (such as ATG23-MYC and ATG23-PA) and perform co-IP to detect dimer formation. This approach has successfully demonstrated that ATG23-PA can co-immunoprecipitate ATG23-MYC, confirming dimerization in vivo .

• Native PAGE analysis: Antibodies can be used in western blotting of native PAGE to compare migration patterns between wild-type and dimerization-deficient mutants. Wild-type ATG23 from cell lysates migrates at the same position as purified dimeric ATG23, while monomeric mutants (like ATG23[LIL]) run faster .

• Cross-linking followed by immunoprecipitation: Cross-linking agents can be used to stabilize dimers prior to immunoprecipitation with ATG23 antibodies, which is particularly useful for transient interactions.

• Mutational analysis: Compare wild-type ATG23 with mutants affecting the dimerization interface (such as L170A,I182A,L189A or L170N-L171N-L173N) using antibody-based detection methods to understand the structural requirements for dimerization .

What methodologies can be used to investigate ATG23's interaction with ATG9?

The ATG23-ATG9 interaction is critical for proper autophagy function and can be investigated using several antibody-based approaches:

• Co-immunoprecipitation studies: Use antibodies against tagged versions of ATG23 (ATG23-MYC, ATG23-PA) to co-immunoprecipitate ATG9 or vice versa. This technique has successfully demonstrated the interaction between these proteins in vivo .

• Pull-down assays with purified components: Use purified ATG23 and membrane fractions containing ATG9, followed by immunodetection with specific antibodies, to demonstrate direct binding. This approach can differentiate between direct and indirect interactions .

• Dimerization-dependent interactions: Compare wild-type ATG23 with dimerization-deficient mutants (e.g., ATG23[LIL]) to study how dimerization affects ATG9 binding using co-IP and pulldown assays with appropriate antibodies .

• Fluorescence microscopy: Use fluorescently tagged proteins and/or antibodies to study co-localization of ATG23 and ATG9 at the PAS and peripheral sites. This approach can reveal spatial and temporal dynamics of their interaction .

• ATG23 mutant analysis: Compare ATG9 binding between wild-type ATG23 and mutants with disrupted dimerization capabilities. Research has shown that mutations in the hydrophobic face of the putative amphipathic helix (L170N-L171N-L173N or L188N-L189N) block both dimerization of ATG23 and its association with ATG9 .

How can researchers use ATG23 antibodies to study its role in vesicle tethering?

ATG23 has been demonstrated to interact with membranes directly and facilitate vesicle tethering. Researchers can use the following antibody-based approaches to study this function:

• In vitro vesicle tethering assays: Purify ATG23 and use it in liposome aggregation assays, followed by immunogold electron microscopy with ATG23 antibodies to visualize its localization at tethering sites .

• Immunofluorescence microscopy: Use ATG23 antibodies to track its localization to membrane contact sites in cells. Compare wild-type cells with those expressing dimerization-deficient mutants to understand the relationship between dimerization and membrane tethering .

• Subcellular fractionation: Use differential centrifugation (S13/P13 and S100/P100 fractions) followed by immunoblotting with ATG23 antibodies to monitor membrane association. This can help determine how mutations or experimental conditions affect membrane binding .

• Structure-function analysis: Use antibodies to detect wild-type ATG23 versus mutants with altered membrane-binding capability to correlate structural features with tethering function. Research has demonstrated that dimerization is critical for proper ATG23 subcellular localization and membrane tethering .

• Proximity-based labeling approaches: Combine antibody-based detection with proximity labeling techniques to identify proteins located near ATG23 at membrane contact sites.

What experimental approaches are recommended for studying the ATG23-Ypt1 interaction?

The interaction between ATG23 and Ypt1 represents an important regulatory mechanism in autophagy. Researchers can investigate this interaction using several methodologies:

• Co-immunoprecipitation assays: Express FLAG-Ypt1 and ATG23-3×HA in appropriate backgrounds (such as atg23Δ) to demonstrate their interaction. This approach has successfully shown that ATG23 interacts preferentially with the GTP-bound form of Ypt1 .

• Bimolecular fluorescence complementation (BiFC): Construct fusion reporters with ATG23 fused to VN (N-terminal fragment of Venus YFP) and Ypt1 fused to VC (C-terminal fragment). Co-expression results in detectable YFP signals, confirming their direct interaction in vivo .

• GST-pulldown assays: Use purified GST-tagged Ypt1 to pull down ATG23 from cell lysates, followed by detection with ATG23 antibodies. This approach can be used to test the effects of mutations on binding .

• Nucleotide-dependent interactions: Compare binding between ATG23 and different Ypt1 variants with disrupted ability to bind GTP or GDP (Ypt1Q67L vs. Ypt1S22N) to determine whether the interaction depends on the nucleotide-bound state of Ypt1 .

• Domain mapping: Study interaction between Ypt1 and various ATG23 mutants affecting the CC1 domain (L170N-L171N-L173N, L188N-L189N) to identify critical residues for binding. Research has shown that these mutations almost completely abolish ATG23-Ypt1 binding .

What controls should be included when validating ATG23 antibodies?

Proper validation of ATG23 antibodies is essential for ensuring reliable experimental results. Researchers should include the following controls:

• Genetic knockout controls: Test antibody specificity in atg23Δ strains to confirm absence of signal. Various deletion strains have been created, including those where the entire coding region of ATG23 is replaced with marker genes like KAN or TRP1 .

• Tagged protein controls: Use epitope-tagged versions of ATG23 (ATG23-HA, ATG23-MYC, ATG23-GFP) to compare with signals from ATG23-specific antibodies .

• Peptide competition assay: Pre-incubate the antibody with the immunizing peptide to demonstrate that specific binding can be blocked.

• Cross-reactivity testing: Test the antibody against related proteins or in systems where ATG23 homologs might be present to ensure specificity.

• Multiple knockout backgrounds: Consider using multiple knockout (MKO) strains lacking 25 genes encoding autophagy proteins to confirm direct interactions without interference from other components .

How should researchers interpret ATG23 antibody results in autophagy assays?

When using ATG23 antibodies in autophagy assays, careful interpretation of results is necessary:

• Partial autophagy phenotypes: Unlike complete autophagy blocks seen with atg9Δ mutants, atg23Δ mutants show partial autophagy defects. This means that intermediate signals in assays using ATG23 antibodies should be interpreted as reflecting reduced efficiency rather than complete inhibition .

• Pathway-specific effects: ATG23 is essential for the Cvt pathway but only facilitates efficient nonselective autophagy. Therefore, different results may be obtained depending on which pathway is being studied .

• Selective vs. nonselective autophagy: When studying ATG23 in autophagy, distinguish between its roles in selective processes (like the Cvt pathway) versus bulk autophagy induced by starvation. Research shows that atg23Δ cells induced only ~40% of the amount of Pho8Δ60 activity (an autophagy marker) compared with wild-type cells under starvation conditions .

• Cell survival interpretation: When analyzing long-term starvation experiments, note that atg23Δ mutants show an intermediate phenotype - they remain viable for several days but begin dying after ~6-8 days, unlike wild-type cells (survive for weeks) or completely autophagy-defective mutants like atg9Δ (die rapidly) .

• Structural vs. efficiency defects: Electron microscopy studies show that atg23Δ cells have reduced numbers of autophagic bodies in the vacuole compared to control strains, indicating decreased efficiency rather than structural defects in autophagosome formation .

What factors might affect ATG23 antibody performance in different experimental contexts?

Several factors can influence ATG23 antibody performance in various experimental settings:

• Membrane association: As a peripheral membrane protein, ATG23 interacts with membranes through electrostatic interactions, which may affect epitope accessibility in certain assays. Consider using different detergent conditions when extracting membrane-bound proteins .

• Dimerization state: ATG23 exists primarily as a homodimer, which may mask certain epitopes. Conditions that affect dimerization (such as mutations or experimental conditions) might alter antibody recognition .

• Protein-protein interactions: ATG23 interacts with several proteins including ATG9 and Ypt1, which could potentially block antibody binding sites in co-IP or immunofluorescence experiments .

• Subcellular localization variability: ATG23 localizes to multiple punctate structures including the PAS and peripheral sites. This dispersed localization may result in different staining patterns depending on cellular conditions and fixation methods .

• Nutritional status effects: ATG23 function changes under different nutritional conditions (nitrogen-rich vs. starvation). These conditions might affect protein modifications, localization, or interaction partners, potentially altering antibody recognition .

How can ATG23 antibodies be used to investigate the relationship between selective and non-selective autophagy?

ATG23 uniquely affects both selective and non-selective autophagy but to different degrees. Researchers can exploit this property using antibody-based approaches:

• Comparative pathway analysis: Use ATG23 antibodies in immunoprecipitation experiments under different conditions (nutrient-rich vs. starvation) to identify condition-specific interaction partners that might explain its differential effects on selective vs. non-selective autophagy .

• Quantitative autophagy assays: Combine ATG23 antibodies with quantitative assays such as the Pho8Δ60 activity assay or monitoring the degradation of specific cargo proteins to correlate ATG23 levels/modifications with autophagy efficiency .

• Structure-function relationship: Use antibodies to detect wild-type ATG23 versus mutants with altered functionality in different autophagy pathways to map domains important for pathway-specific functions.

• Temporal dynamics studies: Use immunofluorescence with ATG23 antibodies to track its localization during different phases of selective and non-selective autophagy to identify temporal differences in recruitment or function.

• Genetic interaction studies: Combine atg23Δ with deletions of genes specifically required for either selective or non-selective autophagy, and use antibodies to study protein localization and interactions in these backgrounds.

What methodological approaches can help investigate the structural basis of ATG23 function?

Understanding the structural features of ATG23 is crucial for elucidating its function. Researchers can use antibody-based approaches in combination with other techniques:

• Domain-specific antibodies: Generate antibodies against specific domains of ATG23 (such as the CC1 domain or amphipathic helix region) to study domain accessibility and function in different contexts .

• Conformational antibodies: Develop antibodies that specifically recognize either monomeric or dimeric forms of ATG23 to track the dimerization state under different conditions.

• Combined structural and immunochemical approaches: Use antibodies to complement structural studies. For example, combine small-angle X-ray scattering (SAXS) data showing ATG23's extended rod-like structure with antibody epitope mapping to relate structure to function .

• Mutational analysis with antibody detection: Create point mutations in the putative amphipathic helix or other domains and use antibodies to study how these mutations affect localization, interactions, and function .

• Cross-linking mass spectrometry: Use antibodies to immunoprecipitate ATG23 complexes after cross-linking, then analyze by mass spectrometry to identify interaction interfaces at the amino acid level.

How can researchers design experiments to study post-translational modifications of ATG23?

While the provided search results don't specifically mention post-translational modifications of ATG23, this is an important research direction that can be investigated using antibody-based approaches:

• Modification-specific antibodies: Develop antibodies that specifically recognize phosphorylated, ubiquitinated, or otherwise modified forms of ATG23 to study regulation under different conditions.

• 2D gel electrophoresis: Combine with ATG23 antibodies to detect shifts in isoelectric point that might indicate modifications.

• Immunoprecipitation followed by mass spectrometry: Use ATG23 antibodies to purify the protein from cells under different conditions, followed by mass spectrometry to identify post-translational modifications.

• Kinase/phosphatase inhibitor studies: Treat cells with various inhibitors, then use ATG23 antibodies to immunoprecipitate the protein and analyze its modification state to identify relevant regulatory pathways.

• TOR pathway connections: Given that TOR-mediated Ypt1 phosphorylation regulates autophagy initiation , investigate whether ATG23 might also be regulated by TOR-dependent modifications using phospho-specific antibodies.

How might ATG23 antibodies contribute to identifying potential human homologs?

Although a human homolog of ATG23 has not yet been definitively identified, antibody-based approaches could help in this search:

• Cross-reactivity screening: Test ATG23 antibodies against human cell lysates to identify potential cross-reactive proteins that might represent functional homologs.

• Immunoprecipitation-mass spectrometry: Use antibodies against known ATG23 interactors (such as ATG9 homologs) to immunoprecipitate complexes from human cells and identify novel binding partners that might function similarly to ATG23.

• Structural epitope conservation: Develop antibodies against functionally important domains of ATG23 (such as the membrane-binding or dimerization regions) and test their reactivity against human proteins with predicted structural similarity.

• Functional complementation testing: Express candidate human homologs in atg23Δ yeast and use ATG23 antibodies to study whether these proteins localize similarly and restore proper autophagy function.

• Comparative interaction studies: Use antibodies to compare the interaction profiles of yeast ATG23 with those of candidate human homologs to identify functional similarities beyond sequence homology .

What are the most promising approaches for studying the temporal dynamics of ATG23 during autophagy?

Understanding the temporal aspects of ATG23 function during autophagy progression requires specialized approaches:

• Time-lapse microscopy: Use fluorescently tagged ATG23 constructs in combination with antibodies against other autophagy markers to track dynamic changes during autophagy induction and progression.

• Synchronized autophagy induction: Combine precise methods for autophagy induction with time-course sampling and antibody-based detection to create a temporal map of ATG23 localization and interactions.

• Pulse-chase experiments: Use antibodies to track the fate of pre-existing versus newly synthesized ATG23 during autophagy to understand protein turnover and recycling.

• Stimulus-dependent studies: Compare ATG23 dynamics under different autophagy-inducing conditions (starvation, rapamycin treatment, etc.) using antibody-based detection methods to identify condition-specific behaviors.

• Correlative light and electron microscopy: Combine immunofluorescence of ATG23 with electron microscopy to precisely localize the protein relative to forming autophagic structures at different time points.